Technical Analysis for VECT - VectivBio Holding AG

Grade Last Price % Change Price Change
D 13.77 8.51% 1.08
VECT closed up 8.51 percent on Friday, May 14, 2021, on 44 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A N/A Flat
Historical VECT trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 8.51%
Hot IPO Pullback Bullish Swing Setup 8.51%
Narrow Range Bar Range Contraction 8.51%
NR7 Range Contraction 8.51%
Lower Bollinger Band Walk Weakness 8.51%
New 52 Week Low Weakness 8.51%
Wide Bands Range Expansion 8.51%
Older End-of-Day Signals for VECT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 10 hours ago
60 Minute Opening Range Breakdown about 12 hours ago
Hot IPO Pullback Entry about 15 hours ago
Rose Above Previous Day's High about 15 hours ago
Up 5% about 15 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for rare conditions. It develops Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as for SBS-IF in patients with colon-in-continuity anatomy. The company was incorporated in 2019 and is headquartered in Basel, Switzerland.
Classification

Sector: Other
Industry: Other
Keywords: Clinical Medicine Gastroenterology Glucagon Like Peptide 1 Biomolecules Short Bowel Syndrome Glucagon Glucagon Like Peptide 2

Is VECT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.6999
52 Week Low 12.6201
Average Volume 81,427
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 14.82
10-Day Moving Average 13.83
Average True Range 1.64
ADX 58.24
+DI 6.03
-DI 18.71
Chandelier Exit (Long, 3 ATRs ) 12.55
Chandelier Exit (Short, 3 ATRs ) 17.54
Upper Bollinger Band 17.18
Lower Bollinger Band 12.47
Percent B (%b) 0.28
BandWidth 31.76
MACD Line -1.42
MACD Signal Line -1.07
MACD Histogram -0.3443
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.33
Resistance 3 (R3) 15.17 14.48 15.07
Resistance 2 (R2) 14.48 14.09 14.57 14.99
Resistance 1 (R1) 14.13 13.84 14.31 14.29 14.90
Pivot Point 13.44 13.44 13.53 13.52 13.44
Support 1 (S1) 13.09 13.04 13.26 13.25 12.64
Support 2 (S2) 12.40 12.80 12.48 12.55
Support 3 (S3) 12.04 12.40 12.47
Support 4 (S4) 12.21